Drugs / ASP7713
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03108755 | May → Aug 2017 | — | Astellas Pharma Europe B.V. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASP7713 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03108755 ↗ |
| Route | Oral | “oral” NCT03108755 ↗ |